marijuana stocks news

General Cannabis, A Wave of Cannabis Legalization Initiatives on the Horizon

On August 10th, CANN shares were trading at $2.17 per share and on September 19th hit a recent high of $4.49 per share. Since then CANN shares had consolidated at about $3.20 per share.

General Cannabis Corp. is expanding its presence on the East Coast with the opening of a New York office. The New York office provides General Cannabis a strategic location to better serve existing East Coast clients while also attracting new talent and partnerships as the cannabis market in the eastern U.S. continues to develop. Further, the opening of the New York office provides a hub for current clients looking for East Coast expansion opportunities.

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT: editor@tradersnewssource.com

SOURCE: Traders News Source


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Trulieve Cannabis Corp. (TCNNF) to Hold Second Quarter 2024 Results Conference Call on

Trulieve Cannabis Corp. to Hold Second Quarter 2024 Results Conference Call on…

$NTRR Has Their Eye on Markets in Oregon, Alaska and D.C. After Cannabis Measures Passed at the Polls

NTRR Eyes Ancillary Market in Oregon, Alaska and D.C. After Voters Pass…

Novus Acquisition (NDEV) MedPlan Issues Next Level Strategy

Novus Cannabis MedPlan Issues Next Level Strategy as it Continues its Profitable…